Biochemical analysis of the CD45-p56 super(lck) complex in Jurkat T cells lacking expression of lymphocyte phosphatase-associated phosphoprotein

• Published in: International immunology Vol. 10; no. 2; pp. 185 - 194
• Main Authors: Bruyns, E, Kirchgessner, H, Meuer, S, Schraven, B
• Format: Journal Article
• Language: English
• Published: 01-02-1998
• ISSN: 0953-8178

In human and mouse lymphocytes the protein tyrosine phosphatase CD45, a key molecule involved in T cell activation, non-covalently associates with the tyrosine kinase p56 super(lck) and lymphocyte phosphatase-associated phosphoprotein (LPAP), a 32 kDa phosphoprotein of unknown function. In order to gain insight into the function of LPAP we have generated an LPAP-deficient Jurkat variant by means of antisense strategies. Analysis of the CD45-p56 super(lck) molecular complex in this cell line revealed that loss of LPAP does not alter the expression or the enzymatic activity of CD45 or p56 super(lck). In addition, the association between CD45 and p56 super(lck) is not affected in LPAP-deficient T cells. These data suggest that LPAP does not regulate the enzymatic activity of CD45 or p56 super(lck) and is not required for the association between these two proteins. In order to identify polypeptides that preferentially associate with LPAP we established a Jurkat variant expressing a chimeric receptor which was composed of the extracellular portion of the human HLA-A2.1 molecule and the full-length LPAP protein. Comparative two-dimensional analysis of CD45 and HLA-A2 immunoprecipitates obtained from these cells following metabolic labeling resulted in the identification of a 43 kDa protein that preferentially associates with LPAP under mild detergent conditions.